2611-33-8

Basic information

• Product Name: (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride
• Synonyms: Phenol, m-(1-methyl-3-propyl-3-pyrrolidinyl)-, hydrochloride, L-;(l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride
• CAS NO: 2611-33-8
• Molecular Formula: C14H21 N O . Cl H
• Molecular Weight: 0
• Mol File: 2611-33-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 336°Cat760mmHg
• Flash Point: 152.3°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 5.94E-05mmHg at 25°C
• CAS DataBase Reference: (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride(2611-33-8)
• EPA Substance Registry System: (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride(2611-33-8)

Safety Data

• Hazardous Substances Data: 2611-33-8(Hazardous Substances Data)

Usage

Description

(l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride, commonly known as Levallorphan, is an opioid receptor antagonist that plays a crucial role in the medical field. It is characterized by its ability to block the effects of opioids in the body, particularly within the central nervous system and the respiratory system. Levallorphan exhibits a high affinity for mu, kappa, and delta opioid receptors, making it a valuable compound in various medical applications.

Uses

Used in Emergency Medicine:
Levalorphan is used as an antidote for opioid overdoses, functioning by reversing the effects of opioids on the central nervous system and respiratory system. It is particularly effective in emergency situations where rapid intervention is required to counteract life-threatening opioid-induced respiratory depression.
Used in Treatment of Opioid-Induced Respiratory Depression:
Levalorphan serves as a treatment for opioid-induced respiratory depression, a condition that can arise from the use of opioids for pain management. By blocking the effects of opioids on the respiratory system, Levallorphan helps to restore normal breathing patterns and prevent potential complications.
Used in Addiction Treatment:
Levalorphan has been studied for its potential in treating addiction and dependence on opioids. As an opioid receptor antagonist, it can help to reduce cravings and withdrawal symptoms associated with opioid addiction, making it a valuable tool in the management of opioid use disorders.
Used in Pharmaceutical Research:
Levalorphan's interaction with opioid receptors has made it a subject of interest in pharmaceutical research. Its high affinity for mu, kappa, and delta opioid receptors provides a foundation for the development of new medications and therapies aimed at addressing various conditions related to opioid use and addiction.

InChI:InChI=1/C14H21NO.ClH/c1-3-7-14(8-9-15(2)11-14)12-5-4-6-13(16)10-12;/h4-6,10,16H,3,7-9,11H2,1-2H3;1H